A carregar...
Durvalumab-induced myocarditis, myositis, and myasthenia gravis: a case report
BACKGROUND: Immune checkpoint inhibitors are effective therapies for a wide range of malignancies. Their increased use has led to a wide range of immune-related adverse effects including skin, gastrointestinal, pulmonary, endocrine, cardiac, and neurologic complications. CASE PRESENTATION: We presen...
Na minha lista:
| Publicado no: | J Med Case Rep |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8165972/ https://ncbi.nlm.nih.gov/pubmed/34053457 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-021-02858-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|